The US drugmaker Eli Lilly said it will stop exporting non-essential medicines to Russia.
The US drugmaker would continue to supply treatments for life-threatening diseases such as cancer and diabetes but that it would suspend all investments, promotional activities and new clinical trials in Russia.
It marks the first time a big US pharmaceutical company has publicly announced plans to restrict exports of some medicines due to the war in Ukraine and comes as other drugmakers distance themselves from Russia, The Financial Times reported.
Any profits generated by sales of essential medicines such as insulin or cancer drugs would be donated to humanitarian relief efforts, said Lilly.
“For nearly 150 years, Lilly has worked to ensure patients have access to the medicines they need, no matter where they may live,” it said in a statement. “Our Russian operations are now only focused on ensuring people suffering from diseases like cancer and diabetes continue to get the Lilly medicines they need.”
Pfizer said this week a voluntary pause in the flow of its medicines to Russia would be in direct violation of the company’s foundational principle of putting patients first. It has said it would donate any profits from its Russian operations to direct humanitarian support for the Ukrainian people. The export of medicines, the materials necessary for making them and medical equipment have been excluded from tough sanctions imposed on Russia by the US, EU and other western nations.
This has meant pharmaceuticals and healthcare are among the only industries still doing substantial business in Russia.
